Neo-adjuvant chemotherapy is used in cases of locally advanced breast cancer (LABC) aiming for local control of the disease and cosmetic breast surgery.
The aim of the work: is to assess the response of LABC to neo-adjuvant chemotherapy by Tc-99m MIBI & Tc99m (V)DMSA scintimammography in relation to histopathological evaluation.
Materials & Method:
24 patients with locally advanced breast carcinoma, aged 30 to 65 years were included. Initial scintimammography using Tc-99m MIBI& Tc-99m (V) DMSA was done using 20 mCi of each tracer. Early images at 20 minutes as well as late images at (2 hours in case of Tc-99m MIBI & 4 hours in case of Tc99m(V)DMSA) were acquired. After 3-4 courses of neo-adjuvant chemotherapy, scintimammography was repeated using both tracers. All the images were assessed qualitatively according to grade of uptake & quantitatively by drawing region of interest over the breast lesion and a mirror image over the contra-lateral normal breast. L/N ratio was calculated for each image. The degree of change in Tc-99m MIBI & Tc-99m (V)DMSA uptake from pre-therapy scan to posttherapy scan was calculated. Correlation between the degree of change of Tc-99m MIBI & Tc-99m(V)DMSA and histopathological percentage of necrosis, antibody expression for angiogenesis& MDR were done.
Results:
Good response was evident in 9 patients, 88.8% of them showed significant degree of change in Tc-99mMIBI uptake ratio, while only 33.4% showed partial degree of change in Tc-99m(V)DMSA uptake ratio. The percentage of change in Tc-99mMIBI uptake in this group ranged from 43% to 58% with mean value of 51.6%, while that of Tc-99m(V)DMSA ranged from -9.2% to 18% with mean value of -2.4%. Partial response was evident in 5 patients. All of them showed partial degree of change in Tc-99mMIBI uptake while Tc-99m(V)DMSA uptake showed no change in all the five patients. The degree of change of Tc-99mMIBI ranged from 4 %to 46% with mean value of 19.7%, while that of Tc-99m(V)DMSA ranged from -5.5% to -19.9% with mean value of -12.4%. Bad response: 10 patients showed bad response. All the ten patients showed no change in Tc99mMIBI uptake ratio, while 50% showed no changed in Tc-99m(V)DMSA uptake ratio. The percentage of degree of change in Tc-99mMIBI ranged from-12% to 17% with mean of 2.59, while that of Tc-99m(V)DMSA ranged from -25 to 5.2 with mean value of -6.7
There was highly statistically significant correlation between degree of change of Tc-99m MIBI & percentage of histopathologic necrosis, angiogenesis as well as antibody expression against MDR (P < 0.01), whereas no significant correlation was found between degree of change of Tc-99m(V)DMSA &
INTRODUCTION
Breast cancer is the most common malignant tumor among women that account for 32% of their cancer and is considered one of the leading causes of death in women in USA (Raymond et • To determine role of radionuclide as in-vivo imaging of multi-drug resistance.
• Comparison of radionuclide imaging with pathological data including MDR, percentage of necrosis and angiogenesis.
PATIENTS AND METHODS
24 female patients with breast carcinoma were included in our study. Their age ranged from 30 years to 65 years old with mean age of 48.14 years. Local axillary examination showed that 15 patients have palpable enlarged firm fixed lymph nodes, while 14 patients' exhibits no axillary node involvement. Tc (V)DMSA was done and assessment of response was estimated qualitatively and quantitatively. Qualitative assessment was done by comparing the grade of uptake before and after neoadjuvant chemotherapy protocol and determine the degree of change in the grade of uptake (no change, Partial change and Significant change). Quantitative assessment: L/N ratio was compared before and after neo-adjuvant chemotherapy protocol. The degree of change was calculated by subtracting L/N ratio of the post-therapy scan from that of the pre-therapy scan divided by the pretherapy scan L/N ratio.
Patients were divided into 3 groups: good, partial and bad responders. Good responders are those who showed significant decrease in grade of uptake with decreased L/N ratio < 1.5. Partial responders are those who showed partial decrease in grade of uptake and L:N ratio but still >1.5.Bad responders showed no change or higher grade of uptake with L/N ratio > 1.5.
Histopathological examination of all the surgical specimens was done to determine the effect of Neo-adjuvant chemotherapy and percentage of necrosis as well as Imunohistochemical staining to detect MDR and angiogenesis. The degree of angiogenesis was classified into mild (+), moderate (++) and significant (+++).
All the results of scintimammography & pathological data were compared and analyzed according to standard statistical methods.
RESULTS

A-
99m Tc MIBI scintimammography:
Good responders: Nine patients (37.5%) out of the twenty four patients showed good response to chemotherapy by histopathological examination. Eight patients (88.88%) out of the nine patients showed significant change in the grade of uptake of Tc-99m MIBI from the initial pre-chemotherapy scan to post chemotherapy scan. There was concordance between the degree of change in the grade of MIBI uptake and the response to chemotherapy, such result was statistically highly significant (r = 0.87). (Fig 1) Quantitatively the percentage of degree of change in the MIBI uptake from the initial prechemotherapy scan to the post chemotherapy scan ranged from 43 % to 58 % with mean value of 51.6% (Table  1) , (Fig. 2A) . Histopathological examination of the surgical specimens revealed that the percentage of necrosis in all nine patients who showed good response was more than 90% necrosis (Fig. 2B) these cases showed mild degree of angiosasis and where MDR negative (Fig. 2C, D) . Partial Responders Five patients out of the twenty four patients showed partial response to neo-adjuvant chemotherapy by histopathological examination. All the five patients showed partial change in the grade of MIBI uptake from the initial pre-chemotherapy scan to the post chemotherapy scan. Quantitatively The patients of this group showed decrease in MIBI uptake ratio from the initial pre-chemotherapy scan to the post chemotherapy scan but still the mean value of post chemotherapy MIBI uptake is more the normal value (1.5).. The percentage of change in the MIBI uptake from the initial pre-chemotherapy scan to the post chemotherapy scan ranged from 4% to 46% with mean value of 19.78% (Table 1) .
Histopathological examination of the surgical specimens revealed that the percentage of necrosis ranged from 50%-90%
Bad responders Ten patients out of the 24 patients showed bad response to neo-adjuvant chemotherapy. All the ten patients showed no change in the grade of MIBI uptake from the initial prechemotherapy scan to the post chemotherapy scan. Quantitatively The percentage of change in MIBI uptake from the initial pre-chemotherapy scan to the post-chemotherapy scan ranged from -12% to 17% with mean value of 2.59%. (Table 1) (Fig. 3A) . Histopathological examination of surgical specimens of the ten patients who showed bad response revealed that the percentage of necrosis of this group of patients was < 50% (Fig.3B) .these case showed high degree of angiogenesis and 3 of them were positive for MDR (Fig. 3C&D) .
Correlation between percentages of change in: percentage of necrosis
Correlation between degree of change of 99m Tc-MIBI from the prechemotherapy scan to the post chemotherapy scan and percentage of necrosis in the studied groups (good, partial & bad responders) were done. It showed highly significant correlation with r = 0.87, p value < 0.01 (Fig.1) .
B99m
Tc (V)DMSA scintimammography: Good responders: Six patients of nine good responders (66.66%) showed no change in the degree of uptake from the initial 99m Tc(V)DMSA prechemotherapy scan to the post chemotherapy scan. The other three patients (33.34%) showed partial degree of change. The degree of change in the grade of (V)DMSA uptake from the initial pre-chemotherapy scan to the postchemotherapy scan in relation to response was statistically not significant (P>0.05). Quantitatively, The percentage of the degree of change in 99m Tc(V)DMSA from the initial pre-chemotherapy scan to the post-chemotherapy scan ranged from -9.2% to 18% with mean value of 2.4% (Table 2) (Fig. 2A) .
Partial responders All the five patients of partial response showed initial high grade of (V)DMSA uptake in the prechemotherapy scan with no change in the grade of uptake from the initial prechemotherapy scan to the post chemotherapy scan. Quantitatively the percentage of the degree of change in 99m Tc-(V)DMSA from the initial prechemotherapy scan to the post chemotherapy scan ranged from -5.59% to -19% with mean value of -12.4% (table 2) Bad responders Five out of the ten patients with poor response showed no change in the grade of Tc-99m (V)DMSA uptake from the pre-therapy scan to the post-chemotherapy scan. The other five patients (50%) showed partial degree of change in the grade of (V)DMSA uptak. Quantitatively The percentage of the degree of change in 99m Tc(V)DMSA from the initial prechemotherapy scan to the post chemotherapy scan ranged from -25 to 5.2% with mean value of -6.7% (Table  2) (Fig. 3A) Tc-MIBI uptake is higher than 43% this could predict good response to neoadjuvant chemotherapy in 89% of the patients.
Similarly, Mankoff et al., (1999), investigated 32 patients with locally advanced breast cancer (LABC) with MIBI scintimammography prior to, after 2 courses and at completion of chemotherapy. They concluded that, the change in L/N ratio was 58% in complete pathological responders & 18% in partial pathological responders (P< 0.005). They also specify a change of ≥ 40 % in the MIBI uptake ratio could identify complete responders with 100% sensitivity and 89% specificity.
Also, Takamura et al., (2001) studied 46 patients with LABC or metastatic breast cancer and found that L/N ratio of MIBI uptake before therapy could predict response to chemotherapy with a PPV, NPV and accuracy of 81%, 96% and 89.1% respectively.
Furthermore, Sciuto et al., (2002)
assessed 30 patients with locally advanced breast cancer by MIBI scintimammography at baseline and after the completion of neo-adjuvant chemotherapy. They stated that with a pretreatment washout rate cut off at 45% the scan yielded a sensitivity of 100% and specificity of 80% for prediction of chemo-resistance. Positive and negative predictive values were 83% and 100% respectively.
Tc-99m (V) DMSA:
Six patients (66.6%) out of the nine patients with percentage of necrosis > 90% who proved to be good responders showed no change in degree of (V)DMSA uptake ratio, while only three patients (33.34%) showed mild degree of change in (V)DMSA uptake ratio from the pre-therapy scan to the post therapy scan with mean value of change of 2.4%.
Five patients showed partial response. They showed no change in the degree of (V)DMSA uptake ratio with mean change value of change -12.4%. Five patients in the group of bad response showed no change in degree of (V)DMSA uptake ratio, while the other five patients (50%) showed partial degree of change in the degree of (V)DMSA uptake ratio with mean value of change -6.7%. So, there was no definite correlation between degree of change in Tc-99m(V) DMSA uptake and histopathological changes.
Angiogenesis:
In the present study, the degree of change of MIBI uptake from the pretherapy scan to the post-therapy scan showed statistically highly significant correlation with angiogenesis (P value < 0.01), while the degree of change of (V) DMSA uptake from the pre-therapy scan to the post therapy scan showed no significant correlation with angiogenesis (P value > 0.05).
Also, Bekis et al., (2005) studied 31 breast lesion with 99mTc-MIBI scintimammography and imunohistochemical staining in attempt to correlate between the MIBI uptake and angiogenesis in breast lesions. They found that there was no statistically significant correlation between the degree of angiogenesis and early L/N ratio ( r = 0.235, P > 0.05), and delayed L/N ratio ( r = 0.18, P > 0.05).On the other hand, they reported that there was high correlation between angiogenesis and washout index ( r = 0.893, P < 0.05) in non invasive breast lesions.
Multi-drug Resistance:
Another important issue in treatment with chemotherapy is evaluation of multidrug resistance (MDR) which is considered as a stand point for further modification of treatment protocol.
A good correlation was found between the expression of Pgp (Pglycoprotein) responsible for multidrug resistance and rate of efflux of Tc-99m sestamibi (Del vecchio et al., 1997), hence Tc-99m sestamibi can be used in evaluation of multidrug resistance (MDR).
In the present study, all the surgical specimens included in the study were subjected to immunohistochemical staining for detection of P-gp expression in relation to the late uptake of both 99mTc-MIBI and Tc-99m(V) DMSA in the initial pre-therapy scan. MIBI scintimammography predicted the phenomenon of MDR with sensitivity of 75% & specificity of 95%. The relation between MDR-1 protein expression (Pglycoprotein) and late Pre-therapy MIBI uptake ratio was statistically significant with P<0.01. (MRP) . They calculated the retention index for every case and deduced that there is high positive correlation between P-gp and retention index (r = -0.88, P = 0.001), but no significant correlation between resistance associated protein (MRP) and retention index (r = -0.12, P = 0.512).
On the other hand, in the current study Tc-(V) DMSA is not related to either P-gp and MDR-1 expression or glutathione (GSH) levels.
CONCLUSION
Tc-99m MIBI scintimammography is valuable in assessment of response of LABC to neo-adjuvant chemotherapy, while Tc-99m (V) DMSA plays no role in assessment of response to neo adjuvant chemotherapy.
99mTc-Sestamibi scintimammography is a valuable method in prediction of multi-drug resistance in locally advanced breast carcinoma, while Tc-99m (V) DMSA has no role in prediction of MDR. 
